Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.22.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Product Information [Line Items]    
Cash FDIC insurance $ 250,000  
Cash SIPC insurance 500,000  
Patent and licensing legal and filing fees and costs $ 315,237 $ 120,160
Revenue Benchmark [Member] | Product Concentration Risk [Member] | General and Administrative Expense [Member]    
Product Information [Line Items]    
Concentration of risk, percentage 29.30% 29.30%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | General and Administrative Expense [Member] | Directors and Corporate Officers [Member]    
Product Information [Line Items]    
Concentration of risk, percentage 31.00% 51.20%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor One [Member]    
Product Information [Line Items]    
Concentration of risk, percentage 63.80% 54.20%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Two [Member]    
Product Information [Line Items]    
Concentration of risk, percentage 11.80% 15.90%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Three [Member]    
Product Information [Line Items]    
Concentration of risk, percentage   13.90%